Clinical Trials Team

Clinical Trials Expert Team

Marc Sirockman, President

Marc Sirockman brings 30 years of industry experience, unique perspectives and passion for excellence to all his client engagements. Following successful field, management and sales training positions in pharma/biotech industries, Marc has developed strategic insights in the complex touchpoint-matrix framework required to engage healthcare providers, caregivers, payers and patients. Marc was named Top 100 Pharmavoice “most inspiring leader” 2013 and 2015. Marc’s mission is to creatively engage with stakeholders to achieve an impactful single, shared voice of truth to drive performance within the complex health ecosystem.

Marc Sirockman, President

Marc Sirockman brings 30 years of industry experience, unique perspectives and passion for excellence to all his client engagements. Following successful field, management and sales training positions in pharma/biotech industries, Marc has developed strategic insights in the complex touchpoint-matrix framework required to engage healthcare providers, caregivers, payers and patients. Marc was named Top 100 Pharmavoice “most inspiring leader” 2013 and 2015. Marc mission is to creatively engage with stakeholders to achieve increased share of “signal voice of truth voice” which is impactful and drive performance within the complex health ecosystem.

David Segarnick, PhD., Chief Medical Officer

With degrees in pharmacology and neurochemistry and two decades in the industry, Dr. Segarnick has worked across most therapeutic areas and has supported the launches of blockbusters like Nexium, Prevnar 13, Tykerb, and Cervarix. Involved in every client initiative, he is an expert at building compelling narratives and bridging the communication gap between Commercial and Medical Affairs in client organizations. Dr. Segarnick was named Top 100 Pharmavoice “most inspiring leader” 2013. Dr. Segarnick is also professor, pharmacology, physiology and neuroscience at Rutgers University/New Jersey Medical School.

David Segarnick, PhD., Chief Medical Officer​

With degrees in pharmacology and neurochemistry and two decades in the industry, Dr. Segarnick has worked across most therapeutic areas and has supported the launches of blockbusters like Nexium, Prevnar 13, Tykerb, and Cervarix. Involved in every client initiative, he is an expert at building compelling narratives and bridging the communication gap between Commercial and Medical Affairs in client organizations. Dr. Segarnick was named Top 100 Pharmavoice “most inspiring leader” 2013. Dr. Segarnick is also professor, pharmacology, physiology and neuroscience at Rutgers University/New Jersey Medical School.

Brian Shaechter, Senior Vice President, Strategic Accounts

Brian has over 25 years of experience in the pharmaceutical, biotechnology, chemical, research, education, and medical device markets. During that time, he brought compounds and devices from the pre-clinical stage to market. Prior to joining MedEvoke, he spent his early career with Baxter Lifesciences, ThermoFisher Scientific, Atcor Medical, and the Artcraft Health organizations, supporting hundreds of global and domestic clients. Brian has a B.A. in economics and minor in finance from the University of Maryland, College Park. He is also certified in the principles of Good Clinical Practice developed by the International Conference on Harmonization.

Brian Shaechter, Senior Vice President, Strategic Accounts

Brian has over 25 years of experience in the pharmaceutical, biotechnology, chemical, research, education, and medical device markets. During that time, he brought compounds and devices from the pre-clinical stage to market. Prior to joining MedEvoke, he spent his early career with Baxter Lifesciences, ThermoFisher Scientific, Atcor Medical, and the Artcraft Health organizations, supporting hundreds of global and domestic clients. Brian has a B.A. in economics and minor in finance from the University of Maryland, College Park. He is also certified in the principles of Good Clinical Practice developed by the International Conference on Harmonization.

Linda Andersen, Director, Strategic Accounts – Clinical Trials

Linda is an accomplished business development manager, dimensional marketer, and solutions-minded problem solver with over 20 years of pharmaceutical industry experience. She is passionate about providing clients with creative strategies that enhance compliance, engagement, and bridge the gap in communication between key stakeholders. This methodology puts emphasis on the entire patient-caregiver experience for improved outcomes for all. Over her career, Linda has developed marketing strategies in the therapeutic areas of endocrinology, rheumatology, oncology, dermatology, neurology, as well as rare diseases. She has contributed to the development of 2 patented patient-education pieces. She holds a B.A. in Communications from Montclair State University.

Linda Andersen, Director, Strategic Accounts – Clinical Trials

Linda is an accomplished business development manager, dimensional marketer, and solutions-minded problem solver with over 20 years of pharmaceutical industry experience. She is passionate about providing clients with creative strategies that enhance compliance, engagement, and bridge the gap in communication between key stakeholders. This methodology puts emphasis on the entire patient-caregiver experience for improved outcomes for all. Over her career, Linda has developed marketing strategies in the therapeutic areas of endocrinology, rheumatology, oncology, dermatology, neurology, as well as rare diseases. She has contributed to the development of 2 patented patient-education pieces. She holds a B.A. in Communications from Montclair State University.

Rich Miller, Chief Creative Officer

Rich is renowned for driving new business, building dynamic teams, and generating award-winning solutions. Previously he was Vice President, Creative Director at Bionical Solutions and Vice President, Creative Director at Artcraft Health. Producing dynamic work for such notable clients as Pfizer, Novartis, Celgene, Astra Zeneca, Merck, and others, his span of therapeutic areas has been multi-dimensional in the Oncology, Endocrinology Immunology, and Pulmonology categories, as well as the Clinical Trial and Medical Device categories. Throughout his career, distinctions have included the MM&M Gold, PM360 Trailblazer, Pharma Choice Gold, New Jersey Ad Club, Interactive Media, Marcom Platinum, Communicator Award of Excellence, Graphic Design USA, and Hermes Gold Awards.

Rich Miller, Chief Creative Officer

Rich is renowned for driving new business, building dynamic teams, and generating award-winning solutions. Previously he was Vice President, Creative Director at Bionical Solutions and Vice President, Creative Director at Artcraft Health. Producing dynamic work for such notable clients as Pfizer, Novartis, Celgene, Astra Zeneca, Merck, and others, his span of therapeutic areas has been multi-dimensional in the Oncology, Endocrinology Immunology, and Pulmonology categories, as well as the Clinical Trial and Medical Device categories. Throughout his career, distinctions have included the MM&M Gold, PM360 Trailblazer, Pharma Choice Gold, New Jersey Ad Club, Interactive Media, Marcom Platinum, Communicator Award of Excellence, Graphic Design USA, and Hermes Gold Awards.

Why MedEvoke for Clinical Trials

© 2019 MedEvoke. All rights reserved

MedEvoke holds certifications from Women’s Business Enterprise National Council (WBENC), National Minority Supplier Development Council Inc (NMSDC), Small Business Administration (SBA), and Diversity Alliance for Science (DA4S).

Contact us

Phone: 908.638.5885

65 Main St.

High Bridge, NJ 08829

© 2019 MedEvoke. All rights reserved

Contact us

Phone: 908.638.5885

65 Main St.

High Bridge, NJ 08829

MedEvoke holds certifications from Women’s Business Enterprise National Council (WBENC), National Minority Supplier Development Council Inc (NMSDC), Small Business Administration (SBA), and Diversity Alliance for Science (DA4S).